Teva Pharmaceutical Industries (TEVA) Short-term Investments (2009 - 2014)

Teva Pharmaceutical Industries has disclosed Short-term Investments across 4 years of filings, most recently posting $82.0 million for Q4 2014.

• Quarterly Short-term Investments rose 4000.0% year-over-year to $82.0 million in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $82.0 million (up 4000.0% YoY) and the FY2014 annual result came in at $82.0 million, up 4000.0% from the prior year.
• Short-term Investments climbed to $82.0 million in Q4 2014, from $2.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $82.0 million in Q4 2014 and troughed at $2.0 million in Q4 2013.
• A 3-year average of $29.3 million and a median of $4.0 million in 2012 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2013 — Short-term Investments sank 50.0% — and 2014, when it surged 4000.0%.
• Tracing TEVA's Short-term Investments over 3 years: stood at $4.0 million in 2012, then plunged by 50.0% to $2.0 million in 2013, then jumped by 4000.0% to $82.0 million in 2014.
• Business Quant data shows TEVA's Short-term Investments at $82.0 million in Q4 2014, $2.0 million in Q4 2013, and $4.0 million in Q4 2012.